Cited by 1,389Genetics, Aging, and Longevity in Model OrganismsTelomeres, Telomerase, and SenescenceAging and Gerontology Research

From discoveries in ageing research to therapeutics for healthy ageing

Open access
Campisi, Judith, Kapahi, Pankaj, Lithgow, Gordon J., Melov, Simon, Newman, John C., Verdin, Eric·2019·Nature

Abstract

For several decades, understanding ageing and the processes that limit lifespan have challenged biologists. Thirty years ago, the biology of ageing gained unprecedented scientific credibility through the identification of gene variants that extend the lifespan of multicellular model organisms. Here we summarize the milestones that mark this scientific triumph, discuss different ageing pathways and processes, and suggest that ageing research is entering a new era that has unique medical, commercial and societal implications. We argue that this era marks an inflection point, not only in ageing research but also for all biological research that affects the human healthspan.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-019-1365-2

Cites

197 of 197 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Inflammaging has been considered a hallmark of aging.

    “Later, inflammaging has been considered a hallmark of aging.3”
  • Metformin is the first drug being tested for age-targeting effects in the TAME clinical trial.

    “is the first drug to be tested for its age-targeting effects in the large clinical trial- TAME (Targeting Aging by MEtformin)”

    From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Campisi et al. 2019

  • Modulating the body's inflammatory balance is expected to increase longevity and reverse or mitigate age-related disease processes.

    “modulating the body’s inflammatory balance is expected to increase longevity and reverse or mitigate age-related disease processes.472–474”
  • Reduction of senescent cells through genetic and pharmacological methods can prevent and alleviate various senescence-related diseases.

    “It has been reported that the reduction of senescent cells through genetic and pharmacological methods can prevent and alleviate various senescence-related diseases [165, 166].”

    From Immunosenescence: a key player in cancer development (2020) · cites this paper as [166]

  • Excessive senescent cells have been demonstrated to play a causal role in driving ageing and chronic diseases using genetic and pharmacologic approaches.

    “Excessive senescent cells have been demonstrated to play a causal role in driving ageing [26] and chronic diseases [18] using genetic and pharmacologic approaches.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Campisi, J., Kapahi, P., Lithgow, G. J., Melov, S., Newman, J. C., & Verdin, E.
Affiliations
Buck Institute for Research on Aging (US)
Corresponding author
Verdin, Eric
Venue
Nature
Published
2019-07-10
Volume
571
Issue
7764
Pages
183-192
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2959728234
Cited by
1,389
References
197
Citations by year
2026: 141 · 2025: 224 · 2024: 265 · 2023: 242 · 2022: 196 · 2021: 173 · 2020: 128 · 2019: 19 · 2018: 1
FWCI
11.19
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
National Institute on Aging (R01AG029631, K08AG048354)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Social Sciences › Psychology › Neuropsychology and Physiological Psychology › Aging and Gerontology Research
Keywords
aging, lifespan extension, healthy aging, genetic variants, longevity, model organisms, healthspan
MeSH terms
Healthy Aging, Aging, Clinical Trials as Topic, Humans, Inflammation, Longevity, Mitochondria, Nutritional Status, Rejuvenation, Signal Transduction, Oxidative Stress, Biomedical Research, Circadian Clocks

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review